Your account is not claimed yet. You can sign up with ORCID to claim your account.

Sheng-Nan Lu (Shen-Nan Lu)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 19

Top Venues

Alimentary pharmacology & therapeutics

The Kaohsiung journal of medical sciences

Liver international : official journal of the International Association for the Study of the Liver

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Yuan-Hung Kuo, Tzu-Hsin Huang, Yi-Hao Yen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Ming-Chao Tsai, Kwong-Ming Kee
Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation. Cancers 15 (12) (2023)
Chien-Hung Chen, Cheng-Yuan Peng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics (2023)
Jing-Houng Wang, Hsin-You Ou, Yi-Hao Yen, Chao-Hung Hung, Sheng-Nan Lu
Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2023)
Yuan-Hung Kuo, Tzu-Hsin Huang, Yi-Hao Yen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen, Ming-Chao Tsai, Kwong-Ming Kee
Nomogram to Predict the Long-Term Overall Survival of Early-Stage Hepatocellular Carcinoma after Radiofrequency Ablation. Cancers 15 (12) (2023)
Hui-Han Hu, Wen-Juei Jeng, Mei-Hung Pan, Wun-Sheng Luo, Chia-Ling Chang, Yen-Tsung Huang, Chien-Yu Su, Chen-Tse Chiang, Chin-Lan Jen, Yu-Chuan Chien, Sheng-Nan Lu, Li-Yu Wang, Li-Rung Huang, Mei-Hsuan Lee, Jessica Liu, Mindie H Nguyen, Chien-Jen Chen, Hwai-I Yang
Serum soluble programmed cell death 1 levels predict spontaneous functional cure in inactive carriers with chronic hepatitis B. Alimentary pharmacology & therapeutics 55 (5) (2022)
Yuan-Hung Kuo, Kwong-Ming Kee, Chao-Hung Hung, Sheng-Nan Lu, Tsung-Hui Hu, Chien-Hung Chen, Jing-Houng Wang
Liver stiffness-based score at sustained virologic response predicts liver-related complications after eradication of hepatitis C virus. The Kaohsiung journal of medical sciences (2021)
Te-Sheng Chang, Kao-Chi Chang, Wei-Ming Chen, Nien-Tzu Hsu, Chih-Yi Lee, Yu-Chih Lin, Wei-Cheng Huang, Wen-Nan Chiu, Jin-Hung Hu, Tung-Jung Huang, Mei-Yen Chen, Sheng-Nan Lu
Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study. BMJ open 11 (7) (2021)
Yuan-Jie Ding, Chung-Kuang Lu, Wei-Ming Chen, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Yung-Yu Hsieh, Chih-Wei Yen, Kao-Chi Chang, Wen-Nan Chiu, Chao-Hung Hung, Sheng-Nan Lu, Te-Sheng Chang
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysis. Journal of gastroenterology and hepatology 36 (10) (2021)
Yu-Chi Lee, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Kai-Che Lo, Yi-Hao Yen, Kwong-Ming Kee, Tsung-Hui Hu, Sheng-Nan Lu, Yuan-Hung Kuo
Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study. The Kaohsiung journal of medical sciences 37 (10) (2021)
Tsung-Hui Hu, Sherry Yueh-Hsia Chiu, Po-Lin Tseng, Chien-Hung Chen, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Kwong-Ming Kee, Ming-Tsung Lin, Kuo-Chin Chang, Meng-Chih Lin, Rong-Nan Chien
Five-year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment-naïve patients with chronic hepatitis B-related compensated cirrhosis in Taiwan. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Yu-Han Huang, Shu-Fen Liao, Seik-Soon Khor, Yu-Ju Lin, Hsuan-Yu Chen, Ya-Hsuan Chang, Yi-Hsiang Huang, Sheng-Nan Lu, Hye-Won Lee, Wen-Ya Ko, Claire Huang, Po-Chun Liu, Yen-Ju Chen, Ping-Feng Wu, Hou-Wei Chu, Pei-Ei Wu, Katsushi Tokunaga, Chen-Yang Shen, Mei-Hsuan Lee
Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank. Alimentary pharmacology & therapeutics 52 (4) (2020)
Yuan-Hung Kuo, Sheng-Nan Lu
Letter: the association between chronic viral hepatitis and metabolic syndrome - Authors' reply. Alimentary pharmacology & therapeutics 49 (2) (2019)
Jing-Houng Wang, Tsung-Hui Hu, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Kuo-Chin Chang, Sheng-Nan Lu
Liver stiffness measurement at complete virological response in hepatoma prediction for HBV-related cirrhosis patient with potent antiviral agent. The Kaohsiung journal of medical sciences 35 (11) (2019)
Yuan-Hung Kuo, Sheng-Nan Lu
Editorial: hepatitis B, fatty liver and metabolic syndrome-Interaction or co-existence? Authors' reply. Alimentary pharmacology & therapeutics 48 (10) (2019)
Yuan-Hung Kuo, Kwong-Ming Kee, Nien-Tzu Hsu, Jing-Houng Wang, Chang-Chun Hsiao, Yi Chen, Sheng-Nan Lu
Using AST-platelet ratio index and fibrosis 4 index for detecting chronic hepatitis C in a large-scale community screening. PloS one 14 (10) (2019)
Yuan-Hung Kuo, Kwong-Ming Kee, Jing-Houng Wang, Nien-Tzu Hsu, Chang-Chun Hsiao, Yi Chen, Sheng-Nan Lu
Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study. Alimentary pharmacology & therapeutics 48 (9) (2018)
Ming-Te Kuo, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Kai-Lung Tsai, Chien-Hung Chen
Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir. Alimentary pharmacology & therapeutics 49 (2) (2018)
Hung-Hsien Chiang, Chuan-Mo Lee, Tsung-Hui Hu, Chao-Hung Hung, Jing-Houng Wang, Sheng-Nan Lu, Hsueh-Chou Lai, Wen-Pang Su, Chia-Hsin Lin, Cheng-Yuan Peng, Chien-Hung Chen
A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir. Liver international : official journal of the International Association for the Study of the Liver 38 (11) (2018)
Yi-Hao Yen, Ming-Tsung Lin, Fang-Ying Kuo, Kuo-Chin Chang, Ming-Chao Tsai, Po-Lin Tseng, Cheng-Kun Wu, Jung-Ting Lin, Tsung-Hui Hu, Sheng-Nan Lu, Jing-Houng Wang, Chao-Hung Hung, Chien-Hung Chen
The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver 38 (6) (2017)
Ming-Chun Ma, Yen-Yang Chen, Shau-Hsuan Li, Yu-Fan Cheng, Chih-Chi Wang, Tai-Jan Chiu, Sung-Nan Pei, Chien-Ting Liu, Tai-Lin Huang, Chen-Hua Huang, Harvey Yu-Li Su, Yen-Hao Chen, Sheng-Nan Lu, Kun-Ming Rau
Intra-arterial chemotherapy with doxorubicin and cisplatin is effective for advanced hepatocellular cell carcinoma. TheScientificWorldJournal 2014 (2014)

Sheng-Nan Lu.css-eqlu8i{font-size:small;padding-left:4px;} (Shen-Nan Lu)

Publication Activity (10 Years)

Top Topics

Top Venues

Sheng-Nan Lu (Shen-Nan Lu)